-Reuters
Exane BNP Paribas Initiates Coverage On Visteon with Neutral Rating
Exane BNP Paribas analyst James Picariello initiates coverage on Visteon (NASDAQ:VC) with a Neutral rating.
Related Posts
Needham Maintains Buy on CryoPort, Raises Price Target to $42
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $41 to $42.
Clene Completes Final Patient Visit In Phase 2 RESCUE-ALS Study: Topline Data Readout Expected Q4 2021
Clene Completes Final Patient Visit in Phase 2 RESCUE-ALS Study: Topline Data Readout Expected Q4 2021
Oddo Securities Initiates Coverage On Schlumberger with Outperform Rating, Announces Price Target of $44.5
Oddo Securities initiates coverage on Schlumberger (NYSE:SLB) with a Outperform rating and announces Price Target of $44.5.